Selective blockade of Nav1.8 function promotes hypoalgesia (213), gain of function mutations of SCN10A in humans can promote painful neuropathy (218) and its optogenetic silencing in DRG attenuates neuropathic pain (219). The gene discussed is SCN10A; the disease is Pain.